Moreover, we highlighted the importance of N-glycosylated LTβR in regulating the Th17/Treg cell balance and suggested that LTβR could increase the sensitivity to the glycolysis inhibitors for cancer prevention, which in turn enhanced the therapy of LTβR (Fig. S7). The gene discussed is LTBR; the disease is cancer.